Wall Street ended lower Wednesday on more declines in technology stocks, but the market pared its losses in the afternoon. The S&P 500 fell 15.59 points, or 0.2%, to 6,395.78. after trimming a loss that reached 1.1% earlier in the day. The Dow Jones Industrial...
Typical X-ray machines, including those found in hospitals and airports, can scan objects from about three feet away. Researchers at the University of South Florida have achieved 97% accuracy at a mile.
A new discovery offers fresh insights into the life cycle of massive stars and their imminent death.
Extremely stripped supernova reveals a silicon and sulfur formation site NatureScientists get a rare peek inside of an exploding star ABC NewsOnionlike Space Explosion May Be a New Type of Supernova The New York TimesAstronomers have glimpsed the core of a dying star – confirming theories of how atoms are made The ConversationA dying star revealed its heart Science News
Fast Track status accelerates regulatory pathway for BioAegis' recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases.Second Fast Track designation in recent months highlights broad potential of rhu-pGSN across multiple diverse inflammation-driven conditions. NORTH BRUNSWICK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for inflammatory diseases, announces that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead product candidate, recombinant human plasma gelsolin (rhu-pGSN), for the treatment of decompression sickness (DCS). The company is currently conducting a Phase 2 study of rhu-pGSN for decompression sickness under a contract awarded by the U.S. Navy's Office of Naval Research to the University of Maryland School of Medicine (UMSOM). This work is the culmination of an extended collaboration with Dr. Stephen Thom, Professor of Emergency Medicine at UMSOM.BioAegis' portfolio is built around plasma gelsolin, a highly conserved and critical immune regulatory protein which rebalances dysfunctional inflammation without suppressing immune function. Fast Track Accelerates Path to Patients for Inflammation-Driven Conditions The FDA Fast Track program is intended to accelerate the development of new therapies for serious conditions with high unmet medical needs. Fast Track status enables more frequent interactions with the FDA, including rolling review of the marketing application, and eligibility for priority review, which can significantly accelerate time to market. For BioAegis, this designation highlights the therapeutic promise of rhu-pGSN and provides a clear regulatory pathway to expedite its development.This marks the second Fast Track designation for BioAegis in recent months following one granted for Acute Respiratory Distress Syndrome (ARDS). These dual designations underscore the breadth and therapeutic potential of rhu-pGSN."Fast Track status is granted for products that are addressing areas of strong unmet need with novel, innovative approaches. Dr. Thom's findings of the ...Full story available on Benzinga.com
In an escalating international dispute, Israel launched a series of diplomatic attacks against several of its Western allies as they prepare to recognize a Palestinian state next month.
In the aftermath of the George Floyd murder, the share of venture capitalist dollars that went to Black businesses jumped by 43%. But that trend was short-lived, according to new Cornell SC Johnson College of Business research.
Nearly 40,000 alumni and student donors supported Cornell in a year that brought in $878 million in new gifts and commitments, the second-highest total in Cornell’s history.
CANBERRA (Reuters) -Rapid loss of Antarctic sea ice could be a tipping point for the global climate, causing sea level rises, changes to ocean currents and...
A rare chance to save 25% on our pick for the best canister vacuum is live at Amazon. We last spotted it at 20% off, but today's offer beats that by an extra $25. When we pitted it against the competition, our testers appreciated its powerful suction, easy-to-maneuver design and durable build.